Sargent Bickham Lagudis’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$17K Hold
220
﹤0.01% 638
2022
Q3
$10K Hold
220
﹤0.01% 685
2022
Q2
$8K Hold
220
﹤0.01% 722
2022
Q1
$9K Hold
220
﹤0.01% 720
2021
Q4
$8K Hold
220
﹤0.01% 737
2021
Q3
$7K Sell
220
-145
-40% -$5.65K ﹤0.01% 761
2021
Q2
$25K Hold
365
﹤0.01% 571
2021
Q1
$21K Hold
365
﹤0.01% 576
2020
Q4
$30K Hold
365
﹤0.01% 492
2020
Q3
$26K Hold
365
﹤0.01% 466
2020
Q2
$30K Hold
365
﹤0.01% 430
2020
Q1
$21K Hold
365
﹤0.01% 462
2019
Q4
$38K Buy
365
+145
+66% +$5.86K ﹤0.01% 425
2019
Q3
$4K Hold
220
﹤0.01% 636
2019
Q2
$6K Buy
+220
New +$4.41K ﹤0.01% 639

Other funds holding AXSM